TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 392 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3 | -84.2% | 167 | -86.3% | 0.00% | – |
| Q2 2023 | $19 | +533.3% | 1,217 | +628.7% | 0.00% | – |
| Q1 2023 | $3 | 0.0% | 167 | 0.0% | 0.00% | – |
| Q4 2022 | $3 | -100.0% | 167 | -89.7% | 0.00% | – |
| Q3 2022 | $21,000 | +950.0% | 1,628 | +874.9% | 0.00% | – |
| Q2 2022 | $2,000 | -95.9% | 167 | -95.1% | 0.00% | – |
| Q1 2022 | $49,000 | -9.3% | 3,390 | -14.6% | 0.00% | – |
| Q4 2021 | $54,000 | -11.5% | 3,971 | +6.1% | 0.00% | – |
| Q3 2021 | $61,000 | -7.6% | 3,744 | -5.0% | 0.00% | – |
| Q2 2021 | $66,000 | +6.5% | 3,940 | +16.2% | 0.00% | – |
| Q1 2021 | $62,000 | +785.7% | 3,390 | +811.3% | 0.00% | – |
| Q3 2020 | $7,000 | +600.0% | 372 | +389.5% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 76 | +68.9% | 0.00% | – |
| Q2 2019 | $1,000 | -87.5% | 45 | -88.7% | 0.00% | – |
| Q1 2019 | $8,000 | – | 397 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |